There is little variation in standard cardiometabolic parameters in children with obstructive sleep apnea syndrome (OSAS) but without severe hypoxemia at baseline or after intervention. Of all measures, overnight heart rate emerged as the most sensitive parameter of pediatric OSAS severity.
Children with DS who underwent AT demonstrated significant reductions in both obstructive and central apneic indices on PSG. A significant number of patients with central sleep apnea demonstrated resolution postoperatively.
A majority of Trisomy 21 patients with severe OSA had residual symptoms following surgical intervention. There is also an increased risk of post-operative airway intervention and increased length of hospital stay in these patients.
Many candidates for AT no longer have OSAS on polysomnography after 7 months of watchful waiting, whereas meaningful improvement in symptoms is not common. In practice, a baseline low AHI and normal waist circumference, or low Pediatric Sleep Questionnaire and snoring score, may help identify an opportunity to avoid AT.
In mild cases of OSA, intra-nasal steroids and other anti-inflammatory medications may give relief in mild cases of OSA, but the long-term safety of these treatments has not been established. Weight loss in obese children has been shown to be effective in selected patients but is limited in practice. Non-invasive ventilation may be effective but compliance can be a major obstacle. Oral appliances are effective by stenting the pharyngeal airway, but research in this area is limited.
Alzheimer’s disease (AD) and obstructive sleep apnea (OSA) are highly prevalent, and the prevalence of OSA syndrome in patients with AD remains unknown. The auhtors collected all available published clinical data and analyzed them through a quantitative meta-analytical approach by calculating the aggregate odds ratio for OSA in AD vs. healthy control was 5.05 and homogeneous. This reflects that patients with AD have a five times higher chance of presenting with OSA than cognitively non-impaired individuals of similar age. Moreover, they also found that around half of patients with AD have experienced OSA at some point after their initial diagnosis. Future research should focus on the pathophysiological intercations betwneen the two syndromes, and establish causality. This evidence also promotes intensive screening for OSA amongst patients with AD.
Overnight rostral fluid shift to the neck and lungs may contribute to the pathogenesis of obstructive sleep apnea (OSA) and central sleep apnea (CSA). The authors hypothesized that exercise training will decrease daytime leg fluid accumulation and overnight rostral fluid shift thereby decreasing the severity of OSA and CSA in patients with coronary artery disease (CAD). Patients with CAD and OSA or CSA (apnea-hypopnea index >15 events per h) were randomized to 4 weeks of aerobic exercise training or to a control group. The Apnea-hypopnea index decreased significantly more in the exercise group than in the control group (p=0.047), in association with a greater reduction in the overnight change in leg fluid volume (p=0.04) and by a significantly greater increase in the overnight change in UA-XSA in the exercise group (p=0.04). This study adds to the expanding literature and the beneficial effects of aerobic exercise in this vulnerable patient population.
In light of recent results of a multicenter RCT (the SERVE-HF trail), and use of adaptive servo-ventilation (ASV) for the treatment of central sleep apnea syndrome (CSAS) related to congestive heart failure (CHF) has been controversial. An update of the 2012 systematic review and meta-analyses were performed that demonstrated an improvement in LVEF and a normalization of AHI in all patients. However, they also found that an increased risk of cardiac mortality in patients with an LVEF of ≤45% and moderate or severe CSA predominant sleep-disordered breathing. These data supported a Standard level recommendation against the use of ASV to treat CHF-associated CSAS in patients with an LVEF of ≤45% and moderate or severe CSAS, and an Option level recommendation for the use of ASV in the treatment CHF-associated CSAS in patients with an LVEF >45% and mild CSAS. The ultimate judgment regarding propriety of any specific care must be made by the clinician as per the AASM.
This article summarizes the evidence on the impact of fluid and salt balance on obstructive sleep apnea severity and reviews the potential anesthetic implications of excessive fluid and salt volume on worsening sleep apnea in the perioperative period.
This systematic review found that patients with OSA had worse outcomes for pulmonary and combined complications versus control patients. The association between OSA and in-hospital mortality varied among studies with 9 studies showing no impact of OSA on mortality, 3 studies suggesting a decrease in mortality and 1 study reporting increased mortality.